<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In Western countries, many <z:e sem="disease" ids="C0014852" disease_type="Disease or Syndrome" abbrv="">esophageal diseases</z:e> result from uncontrolled <z:hpo ids='HP_0002020'>gastroesophageal reflux</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Treatments for <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo>, peptic strictures, and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> still account for a large portion of the esophageal interventions performed by therapeutic endoscopists </plain></SENT>
<SENT sid="2" pm="."><plain>In addition to continued refinements in the treatment of these sequelae, new endoscopic therapies have emerged to treat <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> itself </plain></SENT>
<SENT sid="3" pm="."><plain>This article reviews the available literature on new endoscopic antireflux procedures along with other advances that give the endoscopist unprecedented options in the treatment of <z:e sem="disease" ids="C0014852" disease_type="Disease or Syndrome" abbrv="">esophageal diseases</z:e> </plain></SENT>
</text></document>